Pharming Group N.V. (PHAR)

Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	1,057	685	767	724	580	971
Market Cap Growth	67.66%	-10.69%	5.95%	24.82%	-40.25%	-
Enterprise Value	1,022	629.49	725.16	683.3	549.82	927.49
Last Close Price	15.44	10.07	11.43	11.03	8.94	15.20
PE Ratio	2766.71	-55.94	-71.44	58.05	38.87	27.63
Forward PE	34.48	-	-	-	-	-
PS Ratio	2.92	2.31	3.13	3.52	2.92	4.57
PB Ratio	3.99	3.10	3.51	3.54	3.01	5.29
P/TBV Ratio	-	3.58	3.79	3.81	3.25	5.66
P/FCF Ratio	20.05	-265.22	-40.93	34.34	21.40	12.29
P/OCF Ratio	19.82	-382.08	-44.33	32.24	15.33	11.61
EV/Sales Ratio	2.82	2.12	2.96	3.32	2.76	4.37
EV/EBITDA Ratio	21.33	-2.34	-2.54	-3.75	-3.96	-27.86
EV/EBIT Ratio	24.65	-2.20	-2.41	-3.50	-3.47	-22.29
EV/FCF Ratio	19.39	-243.71	-38.70	32.41	20.29	11.74
Debt / Equity Ratio	-	0.51	0.78	0.81	0.84	0.88
Debt / EBITDA Ratio	-	-0.42	-0.60	-0.92	-1.16	-4.86
Debt / FCF Ratio	-	-43.48	-9.15	7.91	5.97	2.05
Asset Turnover	-	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	-	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.52	3.02	3.33	3.94	4.74	3.14
Current Ratio	4.14	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	0.76%	-5.01%	-4.98%	6.88%	8.50%	25.10%
Return on Assets (ROA)	-3.66%	-85.74%	-59.47%	-43.27%	-26.93%	-10.56%
Return on Invested Capital (ROIC)	-6.80%	-216.08%	-155.03%	-108.94%	-66.86%	-23.24%
Return on Capital Employed (ROCE)	-76.54%	-80.32%	-80.14%	-54.47%	-45.79%	-17.22%
Earnings Yield	0.04%	-1.79%	-1.40%	1.72%	2.57%	3.62%
FCF Yield	4.99%	-0.38%	-2.44%	2.91%	4.67%	8.14%
Buyback Yield / Dilution	-1.68%	-0.81%	-1.06%	-0.32%	-0.81%	-0.29%

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q